Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | SYK | P43405 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7018790 | 0.86 | ALDH1A1 (0.33) | ALDH1A1RAPGEF4MEN1KMT2ACYP1A2 | |
| SCHEMBL6426194 | 0.82 | ALDH1A1 (0.37) | ALDH1A1KMT2ACYP1A2CYP2D6 | |
| SCHEMBL6384395 | 0.78 | GSK3B (0.40) | ALDH1A1MAPTMEN1KMT2ACYP1A2 | |
| SCHEMBL6386722 | 0.77 | ALDH1A1 (0.46) | ALDH1A1MEN1KMT2ACYP1A2CYP2D6 | |
| SCHEMBL6386562 | 0.77 | PIK3CA (0.39) | TP53RAPGEF4SYK | |
| SCHEMBL7014092 | 0.77 | BCL6 (0.36) | ALDH1A1 | |
| SCHEMBL7012728 | 0.75 | EGFR (0.34) | MAPTTP53MEN1KMT2A | |
| SCHEMBL6386739 | 0.75 | NR1I2 (0.38) | — | |
| SCHEMBL7016784 | 0.75 | ALDH1A1 (0.33) | ALDH1A1MAPTTP53RAPGEF4MEN1 | |
| SCHEMBL7012481 | 0.74 | EGFR (0.36) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1326864-A2 | ARYL OR HETEROARYL FUSED IMIDAZOLE COMPOUNDS AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS | PFIZER PHARMACEUTICALS INC. (JP) | 2003-07-16 | — | — | EP | disclosed |
| EP-1326606-A2 | EP4 RECEPTOR INHIBITORS TO TREAT RHEUMATOID ARTHRITIS | PFIZER PHARMACEUTICALS INC. (JP) | 2003-07-16 | — | — | EP | disclosed |
| WO-2002032422-A2 | EP4 RECEPTOR INHIBITORS TO TREAT RHEUMATOID ARTHRITIS | PFIZER PHARMACEUTICALS INC. (JP) | 2002-04-25 | — | — | WO | disclosed |
| WO-2002032900-A2 | ARYL OR HETEROARYL FUSED IMIDAZOLE COMPOUNDS AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS | PFIZER PHARMACEUTICALS INC. (JP) | 2002-04-25 | — | — | WO | disclosed |